Peter Igarashi Selected Research

Cystic Kidney Diseases (Cystic Kidney Disease)

1/2020	Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression.
11/2019	Hepatocyte nuclear factor-1β regulates Wnt signaling through genome-wide competition with β-catenin/lymphoid enhancer binding factor.
1/2018	Long noncoding RNA Hoxb3os is dysregulated in autosomal dominant polycystic kidney disease and regulates mTOR signaling.
10/2015	Transcription Factor Hepatocyte Nuclear Factor-1β (HNF-1β) Regulates MicroRNA-200 Expression through a Long Noncoding RNA.
6/2011	Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases.
6/2008	Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Igarashi Research Topics

Disease

19	Cysts 01/2020 - 10/2002
11	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2020 - 04/2003
6	Cystic Kidney Diseases (Cystic Kidney Disease) 01/2020 - 06/2008
5	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2020 - 06/2008
4	Kidney Diseases (Kidney Disease) 01/2021 - 11/2017
4	Fibrosis (Cirrhosis) 01/2020 - 09/2010
4	Inflammation (Inflammations) 01/2020 - 03/2013
3	Acute Kidney Injury (Acute Renal Failure) 12/2019 - 05/2003
3	Renal cysts and diabetes syndrome 12/2007 - 03/2004
2	Proteinuria 01/2018 - 03/2013
2	Body Weight (Weight, Body) 04/2008 - 01/2008
2	Carcinogenesis 01/2008 - 02/2005
2	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 11/2005 - 03/2005
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Sepsis (Septicemia) 12/2019
1	Hypokalemia 11/2017
1	Disease Progression 06/2013
1	Lupus Nephritis 03/2013
1	Ischemia 09/2012
1	Prune Belly Syndrome 01/2012
1	Acidosis 06/2009
1	Splenomegaly 04/2009
1	Birt-Hogg-Dube Syndrome 01/2008
1	Diabetes Mellitus 12/2007
1	Polyneuropathies (Polyneuropathy) 09/2007
1	Amyloidosis 09/2007
1	Leiomyomatosis 04/2007
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2007
1	Renal Insufficiency (Renal Failure) 11/2005
1	Reperfusion Injury 07/2005
1	Hypersensitivity (Allergy) 03/2004
1	Atrophy 02/2004

Drug/Important Bio-Agent (IBA)

8	Hepatocyte Nuclear Factor 1-betaIBA 01/2010 - 10/2002
4	MicroRNAs (MicroRNA)IBA 01/2020 - 12/2012
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2010
3	CateninsIBA 11/2019 - 09/2012
3	Proteins (Proteins, Gene)FDA Link 09/2013 - 11/2006
2	Long Noncoding RNAIBA 01/2020 - 01/2018
2	ChromatinIBA 01/2020 - 01/2009
2	RNA (Ribonucleic Acid)IBA 10/2018 - 01/2018
2	Urea (Carbamide)FDA LinkGeneric 01/2018 - 03/2013
2	Tamoxifen FDA LinkGeneric 01/2018 - 03/2013
2	NitrogenIBA 01/2018 - 03/2013
2	Pharmaceutical PreparationsIBA 01/2017 - 07/2010
2	Sirolimus (Rapamycin)FDA Link 07/2010 - 01/2008
2	beta CateninIBA 02/2005 - 04/2003
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	X-Box Binding Protein 1IBA 12/2019
1	LipopolysaccharidesIBA 12/2019
1	EndotoxinsIBA 01/2018
1	Bovine Serum AlbuminIBA 01/2018
1	Cyclic AMP (AMP, Cyclic)IBA 01/2018
1	NucleotidesIBA 01/2018
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2018
1	InflammasomesIBA 01/2018
1	Potassium Channels (Potassium Channel)IBA 11/2017
1	ElectrolytesIBA 11/2017
1	TRPP Cation ChannelsIBA 09/2013
1	CreatinineIBA 03/2013
1	Kallikreins (Kallikrein)IBA 03/2013
1	Ribonuclease III (RNase III)IBA 12/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	A Kinase Anchor ProteinsIBA 06/2011
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 06/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2010
1	alpha2 Subunit Collagen Type IIBA 09/2010
1	CollagenIBA 09/2010
1	AmmoniaIBA 06/2009
1	LipidsIBA 06/2009
1	AcidsIBA 06/2009
1	Glycoproteins (Glycoprotein)IBA 06/2009
1	Peptides (Polypeptides)IBA 04/2009
1	AutoantibodiesIBA 04/2009
1	KinesinsIBA 01/2009
1	triptolideIBA 09/2008
1	Phosphotransferases (Kinase)IBA 06/2008
1	U 0126 (UO 126)IBA 06/2008
1	Cre recombinaseIBA 06/2008
1	Glucose (Dextrose)FDA LinkGeneric 04/2008
1	Saline SolutionIBA 04/2008
1	BuffersIBA 01/2008
1	Prealbumin (Transthyretin)IBA 09/2007
1	Messenger RNA (mRNA)IBA 05/2007
1	Fumarate Hydratase (Fumarase)IBA 04/2007
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2006
1	Bromodeoxyuridine (BrdU)IBA 07/2005
1	VimentinIBA 07/2005
1	Deoxyribonucleases (DNase)FDA Link 03/2004
1	Inositol (Myoinositol)IBA 02/2004
1	Aldehyde Reductase (Aldose Reductase)IBA 02/2004
1	Betaine (C.B.B.)FDA Link 02/2004
1	gamma-Aminobutyric Acid (GABA)IBA 02/2004
1	ErbB Receptors (EGF Receptor)IBA 04/2003
1	kinesin-IIIBA 04/2003
1	Cadherins (E-Cadherin)IBA 10/2002

Therapy/Procedure

3	Therapeutics 01/2020 - 05/2003
1	Traction 01/2021
1	Intraperitoneal Injections 01/2018